NCT01430923 Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost Status UNKNOWN Phase NA
NCT01426867 A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% Status COMPLETED Phase PHASE2
NCT01415401 Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada Status COMPLETED Phase PHASE4
NCT01410188 Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT01379144 A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension Status COMPLETED Phase PHASE2
NCT01369771 The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma Status COMPLETED Phase PHASE4
NCT01361841 Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma Status UNKNOWN Phase NA
NCT01357616 Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT01342081 DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% Status COMPLETED Phase PHASE3
NCT01312454 Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C Status TERMINATED Phase PHASE2
NCT01310777 Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT01309204 Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT01306461 Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations Status COMPLETED Phase PHASE3
NCT01298700 Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4